| Overview |
| bs-3979R |
| ENO3 Polyclonal Antibody |
| WB, IHC-P, IHC-F, IF, Flow-Cyt |
| Human, Mouse, Rat |
| Cow, Sheep, Pig, Horse, Chicken |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human ENO3 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 2027 |
| P13929 |
| Cytoplasm |
| MSE; GSD13; Beta-enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 3; Muscle-specific enolase; Skeletal muscle enolase; ENO3 |
| ENO3 is also known as beta enolase, one of the three enolase isoenzymes found in mammals. A switch from alpha enolase to beta enolase occurs in muscle tissue during development and ENO3, a homodimer, is found in skeletal muscle cells in the adult and appears to have a function in striated muscle development and regeneration. Mutations can result in decreased stability of the enzyme and be associated with a glycogen storage myopathy. This results in exercise-induced myalgias, generalized muscle weakness and fatigability. |
| Application Dilution |
| WB |
IHC-P1:200-400 |
| IHC-P |
|
| IHC-F |
|
| IF |
|
| Flow-Cyt |
|
Powered by Bioz